Financials data is unavailable for this security.
View more
Year on year Lifecore Biomedical Inc grew revenues 24.20% from 103.27m to 128.26m while net income improved from a loss of 99.56m to a gain of 12.01m.
Gross margin | 32.63% |
---|---|
Net profit margin | 7.27% |
Operating margin | -6.89% |
Return on assets | 3.68% |
---|---|
Return on equity | 263.40% |
Return on investment | 4.35% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Lifecore Biomedical Inc fell by 10.63m. Cash Flow from Financing totalled 7.51m or 5.85% of revenues. In addition the company used 217.00k for operations while cash used for investing totalled 17.92m.
Cash flow per share | 0.5431 |
---|---|
Price/Cash flow per share | 8.83 |
Book value per share | 1.76 |
---|---|
Tangible book value per share | 1.17 |
More ▼
Balance sheet in USDView more
Current ratio | 2.08 |
---|---|
Quick ratio | 1.06 |
Total debt/total equity | 2.25 |
---|---|
Total debt/total capital | 0.6923 |
More ▼